154 related articles for article (PubMed ID: 12145804)
1. Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum.
Wlk M; Wang CC; Venihaki M; Liu J; Zhao D; Anton PM; Mykoniatis A; Pan A; Zacks J; Karalis K; Pothoulakis C
Gastroenterology; 2002 Aug; 123(2):505-15. PubMed ID: 12145804
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation.
Anton PM; Gay J; Mykoniatis A; Pan A; O'Brien M; Brown D; Karalis K; Pothoulakis C
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8503-8. PubMed ID: 15159534
[TBL] [Abstract][Full Text] [Related]
3. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
Webster EL; Barrientos RM; Contoreggi C; Isaac MG; Ligier S; Gabry KE; Chrousos GP; McCarthy EF; Rice KC; Gold PW; Sternberg EM
J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
[TBL] [Abstract][Full Text] [Related]
5. Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats.
Castagliuolo I; Karalis K; Valenick L; Pasha A; Nikulasson S; Wlk M; Pothoulakis C
Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G539-45. PubMed ID: 11254479
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
Broadbear JH; Winger G; Rivier JE; Rice KC; Woods JH
Neuropsychopharmacology; 2004 Jun; 29(6):1112-21. PubMed ID: 14997174
[TBL] [Abstract][Full Text] [Related]
7. Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis.
Cavalcante IC; Castro MV; Barreto AR; Sullivan GW; Vale M; Almeida PR; Linden J; Rieger JM; Cunha FQ; Guerrant RL; Ribeiro RA; Brito GA
Infect Immun; 2006 May; 74(5):2606-12. PubMed ID: 16622196
[TBL] [Abstract][Full Text] [Related]
8. Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats.
Briscoe RJ; Cabrera CL; Baird TJ; Rice KC; Woods JH
Brain Res; 2000 Oct; 881(2):204-7. PubMed ID: 11036160
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.
Krause K; Schnitger A; Fimmel S; Glass E; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013
[TBL] [Abstract][Full Text] [Related]
10. Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors.
Cantarella G; Lempereur L; Lombardo G; Chiarenza A; Pafumi C; Zappalà G; Bernardini R
Br J Pharmacol; 2001 Oct; 134(4):837-44. PubMed ID: 11606324
[TBL] [Abstract][Full Text] [Related]
11. Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats.
van Tol EA; Petrusz P; Lund PK; Yamauchi M; Sartor RB
Gut; 1996 Sep; 39(3):385-92. PubMed ID: 8949642
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses.
Kokkotou E; Torres D; Moss AC; O'Brien M; Grigoriadis DE; Karalis K; Pothoulakis C
J Immunol; 2006 Sep; 177(5):3355-61. PubMed ID: 16920976
[TBL] [Abstract][Full Text] [Related]
13. The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.
Dinopoulou V; Partsinevelos GA; Mavrogianni D; Anagnostou E; Drakakis P; Makrigiannakis A; Chrousos GP; Loutradis D
Endocrinology; 2013 Jan; 154(1):222-31. PubMed ID: 23211705
[TBL] [Abstract][Full Text] [Related]
14. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
15. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.
Webster EL; Lewis DB; Torpy DJ; Zachman EK; Rice KC; Chrousos GP
Endocrinology; 1996 Dec; 137(12):5747-50. PubMed ID: 8940412
[TBL] [Abstract][Full Text] [Related]
17. Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress.
Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
Neuroendocrinology; 2001 May; 73(5):293-301. PubMed ID: 11399902
[TBL] [Abstract][Full Text] [Related]
18. A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum.
Castagliuolo I; LaMont JT; Qiu B; Nikulasson ST; Pothoulakis C
Gastroenterology; 1996 Aug; 111(2):433-8. PubMed ID: 8690209
[TBL] [Abstract][Full Text] [Related]
19. Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum.
la Fleur SE; Wick EC; Idumalla PS; Grady EF; Bhargava A
Proc Natl Acad Sci U S A; 2005 May; 102(21):7647-52. PubMed ID: 15883387
[TBL] [Abstract][Full Text] [Related]
20. Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats.
Castagliuolo I; Keates AC; Qiu B; Kelly CP; Nikulasson S; Leeman SE; Pothoulakis C
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4788-93. PubMed ID: 9114070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
